Clinical Trials on CD20 Positive in United Kingdom
Total 2301 results
-
Global Alliance for TB Drug DevelopmentCompleted
-
Global Alliance for TB Drug DevelopmentCompleted
-
Global Alliance for TB Drug DevelopmentCompletedFood Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)TuberculosisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of General Medical Sciences (NIGMS)RecruitingStaphylococcus Aureus InfectionUnited States
-
Jonathan GisserRecruitingClostridium DifficileUnited States
-
Methodist Health SystemCompleted
-
University of NebraskaTerminatedStaphylococcus AureusUnited States
-
Global Alliance for TB Drug DevelopmentCompleted
-
Sequella, Inc.Quintiles, Inc.CompletedTuberculosisUnited States
-
DynPort Vaccine Company LLC, A GDIT CompanyCompletedAnthraxUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institutes of Health Clinical Center (CC)CompletedAnthraxUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedStaphylococcal InfectionUnited States
-
University of Maryland, BaltimoreCompleted
-
National Cancer Institute (NCI)Active, not recruitingHormone Receptor-Positive Breast | Gynecologic | Desmoid | Hormone Receptor-Positive NeoplasmsUnited States
-
Ohio State UniversityNational Institute on Drug Abuse (NIDA); Massachusetts General Hospital; University... and other collaboratorsRecruitingHIV-positive IndividualsUnited States
-
National Cancer Institute (NCI)CompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
University of California, Los AngelesRecruiting
-
Emergent BioSolutionsNational Institutes of Health (NIH)Completed
-
University of California, San DiegoDepartment of Health and Human Services; Proteus Digital Health, Inc.CompletedTuberculosisUnited States
-
QIAGEN Gaithersburg, IncCompleted
-
Elusys TherapeuticsCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
Fraunhofer, Center for Molecular BiotechnologyCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
PharmAthene, Inc.Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaboratorsTerminated
-
Montefiore Medical CenterMerck Sharp & Dohme LLCTerminatedClostridium DifficileUnited States
-
Crouse HospitalJana Shaw, MD; Steven Gross, MD; David Martin, RN; Dale Franz, RPh; Rachel CareyCompletedStaphylococcusUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
AerasCompleted
-
Pfenex, IncDepartment of Health and Human ServicesCompleted
-
PharmAthene, Inc.National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompleted
-
PharmAthene, Inc.Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaboratorsSuspended
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingBiodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PETTuberculosisUnited States
-
VA Office of Research and DevelopmentTerminatedMicrobiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) (MATCH)Clostridium Difficile InfectionUnited States
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosisUnited States
-
QIAGEN Gaithersburg, IncCompleted
-
QIAGEN Gaithersburg, IncCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Withdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States
-
New York Medical CollegeRoswell Park Cancer InstituteRecruitingDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | CD20+ Lymphoblastic Lymphoma | Follicular Lymphoma, Grade IIIUnited States